Q1 2025 Earnings Call Transcript May 13, 2025 Biodesix, Inc. reports earnings inline with expectations. Reported EPS is $-0.08 EPS, expectations were $-0.08. Operator: Good day and thank you for ...

A dedicated onconephrology service at Brigham and Women’s Hospital has improved kidney outcomes in patients treated for ...

CNN anchor and breast cancer patient Sara Sidner, Dr. Vinod Balachandran, and Novartis U.S. president Victor Bulto discussed ...

Yahoo Sports senior NBA reporter Vincent Goodwill spoke to the 3-time NBA champion and Hall of Famer about the Minnesota ...

Optical fibres are now being used to monitor radiation therapy with hair-thin precision – making treatments safer and more ...

The progress made in liver disease research to date presents an opportunity for further advancements in the near future.

Andrew Hertler, M.D., chief medical officer emeritus at Evolent, discusses the results of a recent paper in the Journal of ...

According to the American Cancer Society, it is estimated that more than two million new cancer cases will be diagnosed and ...

Racial stigma regarding opioid use disorder (OUD) and opioid misuse affect access to cancer pain management for patients in ...

The Gazette will host a series of free, virtual panel discussions this week aimed at exploring Iowa's cancer rates, the ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

TURKU, FI / ACCESS Newswire / May 12, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - BEXMAB data highlights meaningful clinical benefit, with beneficial immunological and hematological impact in ...